Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.47 |
| ▸ | F2 | P00734 | 1/20 | 0.46 |
| ▸ | PLAU | P00749 | 1/20 | 0.46 |
| ▸ | ELANE | P08246 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.45 |
| ▸ | FLT1 | P17948 | 1/20 | 0.45 |
| ▸ | FLT4 | P35916 | 1/20 | 0.45 |
| ▸ | KDR | P35968 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31369141 | 1.00 | LMNA (0.50) | LMNANFE2L2ALDH1A1KMT2AHTT | |
| SCHEMBL11610888 | 0.91 | KMT2A (0.50) | LMNANFE2L2ALDH1A1KMT2AHTT | |
| SCHEMBL10952578 | 0.91 | ALDH1A1 (0.58) | LMNANFE2L2ALDH1A1KMT2AHTT | |
| SCHEMBL14274483 | 0.89 | NPC1 (0.54) | NFE2L2ALDH1A1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL11756227 | 0.89 | MAPK13 (0.53) | NFE2L2ALDH1A1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL9856886 | 0.89 | ALDH1A1 (0.62) | LMNANFE2L2ALDH1A1KMT2AHTT | |
| SCHEMBL11057757 | 0.88 | CSNK2A1 (0.60) | NFE2L2HTTTP53TDP1RAB9A | |
| SCHEMBL11658935 | 0.88 | NFE2L2 (0.42) | LMNANFE2L2ALDH1A1KMT2AHTT | |
| SCHEMBL9420260 | 0.85 | NFE2L2 (0.55) | LMNANFE2L2ALDH1A1KMT2AHTT | |
| SCHEMBL14029260 | 0.85 | NFE2L2 (0.44) | LMNANFE2L2ALDH1A1KMT2AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025059098-A2 | PHOTOCATALYTIC CARBOXYLATION OF SUBSTRATES WITH CARBON OXIDE | NEW IRIDIUM INC. (US) | 2025-03-20 | — | — | WO | disclosed |
| CN-115179545-A | Compositions and articles for additive manufacturing and methods of use thereof | 科思创(荷兰)有限公司 | 2022-10-14 | — | — | CN | disclosed |
| WO-2022202414-A1 | PROTECTIVE TAPE, SEMICONDUCTOR PROTECTIVE TAPE, AND METHOD FOR PRODUCING SEMICONDUCTOR DEVICE | 積水化学工業株式会社 | 2022-09-29 | — | — | WO | disclosed |
| CN-113302216-A | Limonene-based (meth) acrylates for 3D printing | 巴斯夫欧洲公司 | 2021-08-24 | — | — | CN | disclosed |
| US-10191374-B2 | Resist underlayer film-forming composition | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2019-01-29 | — | — | US | disclosed |
| US-20170153548-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-06-01 | — | — | US | disclosed |
| US-8742028-B2 | Solid support for Fmoc-solid phase synthesis of peptide acids | MALLINCKRODT LLC (US) | 2014-06-03 | — | — | US | disclosed |
| EP-2427474-A1 | SOLID SUPPORT FOR FMOC-SOLID PHASE SYNTHESIS OF PEPTIDE ACIDS | Mallinckrodt LLC (US) | 2012-03-14 | — | — | EP | disclosed |
| US-20100286359-A1 | Solid Support for FMOC-Solid Phase Synthesis of Peptide Acids | MALLINCKRODT INC. (US) | 2010-11-11 | — | — | US | disclosed |
| WO-2010129520-A1 | SOLID SUPPORT FOR FMOC-SOLID PHASE SYNTHESIS OF PEPTIDE ACIDS | MALLINCKRODT INC. (US) | 2010-11-11 | — | — | WO | disclosed |
| US-4897490-A | DERIVATIVES OF BETA-HYDROXY,OMEGA-DIPHENYL,TETRAZOL-5-YL ALK-OMEGA-ENOIC ACID, ESTER OR LACTONE | BRISTOL-MEYERS COMPANY (US) | 1990-01-30 | — | — | US | disclosed |
| EP-0172427-B1 | PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER | Shin-Etsu Chemical Co., Ltd. (JP) | 1989-07-05 | — | — | EP | disclosed |
| WO-1988006584-A1 | ANTIHYPERCHOLESTEROLEMIC TETRAZOLE COMPOUNDS | BRISTOL-MYERS COMPANY (US) | 1988-09-07 | — | — | WO | disclosed |
| US-4769502-A | Alkynol type compounds and alcohol-separating process | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1988-09-06 | — | — | US | disclosed |
| US-4758639-A | Process for production of vinyl polymer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-19 | — | — | US | disclosed |
| US-4757124-A | Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0178331-A1 | ALKYNOL COMPOUNDS AND ALCOHOL SEPARATING AGENTS | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) | 1986-04-23 | — | — | EP | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
| US-4134917-A | Method for the denitrosation of organic nitrosamines | AMERICAN CYANAMID COMPANY (US) | 1979-01-16 | — | — | US | disclosed |
| US-4071540-A | MALEIC OR PHTHALIC | CHEVRON RESEARCH COMPANY (US) | 1978-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286359-A1 | Solid Support for FMOC-Solid Phase Synthesis of Peptide Acids | MAX, NPPA, PTMS | LMNA 3522/4885NFE2L2 3286/4885ALDH1A1 4730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.